Behind the Headache: Comprehensive Migraine Management, The Role of Medicinal and Holistic Therapies

Authors

Dr Saumya Harsh Mittal  1 , Dr Salony Mittal  2
Associate Professor, Department of Medicine, SMSR, Greater Noida, Uttar Pradesh, India. 1 , Professor, Department of Pathology, SMSR, Greater Noida, Uttar Pradesh, India. 2
“crossref”/
Views: 29  
Downloads: 18  

##plugins.themes.bootstrap3.article.main##

Abstract

Migraine is a prevalent and disabling neurological condition characterized by recurrent, intense headaches, often accompanied by nausea, light sensitivity, and aura. The management of migraines typically involves pharmacological treatments, but recent advancements have emphasized the importance of a holistic approach that integrates conventional, newer, and alternative therapies. The full spectrum of migraine treatment, focuses on acute and preventive medications, newer treatments such as CGRP inhibitors and neuromodulation techniques, and non-pharmacological therapies including nutrition, stress management, and physical therapies. By combining medications, innovative therapies, and complementary treatments, a more comprehensive, personalized, and effective management plan can be developed to reduce the frequency, intensity, and impact of migraines. The importance of addressing migraine triggers, such as diet, sleep, and stress, is emphasized to promote long-term migraine prevention and overall well-being. The integration of these approaches holds promise for improving patient outcomes and empowering individuals to take an active role in managing their condition.

##plugins.themes.bootstrap3.article.details##

Behind the Headache: Comprehensive Migraine Management, The Role of Medicinal and Holistic Therapies. (2025). Annals of Medicine and Medical Sciences, 843-851. https://doi.org/10.5281/
Review Article

Copyright (c) 2025 Dr Saumya Harsh Mittal, Dr Salony Mittal

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Creative Commons License All articles published in Annals of Medicine and Medical Sciences are licensed under a Creative Commons Attribution 4.0 International License.

[1] Buse DC, Lipton RB, Sereno J, et al. Migraine: Epidemiology, burden, and comorbidity. Neurol Clin. 2010;28(4):797-814.

[2] Lipton RB, Bigal ME, Diamond M, et al. The burden of migraine: Clinical and economic outcomes. J Clin Psychiatry. 2005;66(7):1462-1469.

[3] Ferrante A, Cananzi F, Tontodonati M, et al. The Evolution of Migraine: Ancient and Modern Perspectives. J Headache Pain. 2012.

[4] Shastri A. Sushruta Samhita: Ayurvedic Insights into Migraines. Ayurveda J. 2009.

[5] Khan MA. Unani Medicine and Migraine Treatment. J Tradit Complement Med. 2015;5(4):249-258.

[6] Russell MB. History and Epidemiology of Migraine. J Neurol. 1998;245(6):35-39.

[7] Lipton RB, Dodick DW, Goadsby PJ, et al. Triptans in the Treatment of Migraine. Lancet. 1998;352(9137):1659-1664.

[8] Barlow DH, et al. The Efficacy of Anti-Nausea Medications in Migraine Treatment. J Clin Neurol. 2017;20(5):247-254.

[9] Leonetti C, et al. Indomethacin in the acute treatment of headache. Cephalalgia. 2016;36(7):610-616.

[10] Barlow DH, et al. Anti-nausea medications in the acute treatment of migraine. Am J Gastroenterol. 2018;113(9):1395-1400.

[11] Iezzi D, et al. Opioid use in migraine treatment: A review of risks and alternatives. Neurology. 2018;90(1):14-22.

[12] Nappi G, et al. Mechanism of action of lasmiditan in the acute treatment of migraine. Neurol Sci. 2020; 41(5): 1111-1117. (12)

[13] Lipton RB, et al. Safety and efficacy of lasmiditan for acute treatment of migraine: a randomized clinical trial. JAMA Neurol. 2020; 77(4): 464-472. (13)

[14] Martelletti P, de Coonis L, Charlier P. Beta-blockers in the prevention of migraine: efficacy and safety. J Headache Pain. 2018;19(1):23. doi:10.1186/s10194-018-0847-9.

[15] Silberstein SD. Topiramate for the prevention of episodic migraine: A review of the evidence. J Clin Neurol. 2018;14(2):155-162. doi:10.3988/jcn.2018.14.2.155.

[16] Rapoport AM, Sheftell FD. Tricyclic antidepressants in migraine prophylaxis: A review of the evidence. Headache. 2003;43(9):1020-1024. doi:10.1046/j.1526-4610.2003.03116.x.

[17] Goadsby PJ, Reuter U, Hallström Y, et al. A controlled trial of erenumab for episodic migraine. N Engl J Med. 2017;377(22):2123-2132. doi:10.1056/NEJMoa1705848.

[18] Dodick DW, Turkel CC, DeGryse RE, et al. OnabotulinumtoxinA for chronic migraine: results from the PREEMPT clinical program. Cephalalgia. 2010;30(7):793-803. doi:10.1111/j.1468-2982.2010.02036.x.

[19] Shukla V, Singh S. Efficacy of Ashwagandha in treating stress-induced migraines. Journal of Ayurveda and Integrative Medicine. 2020;11(3):181-187.

[20] Patil V, Rani V. Ayurvedic treatment for chronic migraine: A holistic approach. Indian Journal of Traditional Knowledge. 2018;17(4):645-650.

[21] Goebel A, Molsberger F. Effectiveness of peppermint oil in treating tension headaches: A clinical study. Cephalalgia. 2019;39(4):355-362.

[22] Smith L, Wright H. Aromatherapy in the treatment of migraine: A systematic review. Journal of Alternative and Complementary Medicine. 2018;24(7):590-596.

[23] Homeopathy for migraine: Evidence and experience. Journal of Homeopathic Medicine. 2020;39(2):120-126.

[24] Khatib G, Mahmoud S. Efficacy of Unani medicine in treating migraine headaches: A clinical review. Journal of Ethnopharmacology. 2021; 260:113207.

[25] Lefaucheur JP, Drouot X, Vercueil L, et al. Repetitive transcranial magnetic stimulation for the treatment of chronic migraine: a randomized controlled trial. Neurology. 2008;70(20):1738-1745.

[26] Mosimann UP, Langewitz W, Sturzenegger M, et al. Repetitive transcranial magnetic stimulation (rTMS) for the treatment of chronic migraine: A randomized, double-blind, placebo-controlled trial. Cephalalgia. 2005;25(12):1083-1088.

[27] Mainardi F, Stocchi F, Cortelli P, et al. Occipital nerve stimulation for refractory chronic migraine: results from a pilot study. Lancet Neurol. 2009;8(4):391-396.

[28] Martelletti P, Nappi G, La Grutta S, et al. Occipital nerve stimulation for chronic migraine. Cephalalgia. 2012;32(4):283-291.

[29] Ayache SS, Confort-Gouny S, Galanaud D, et al. Transcranial direct current stimulation for the treatment of chronic migraine. Neurology. 2013;80(6):563-569.

[30] Antal A, Brunoni AR, Poreisz C, et al. Transcranial direct current stimulation for the treatment of chronic migraine. Brain Stimulation. 2017;10(5):999-1007.

[31] Cady RK, Blumenfeld AM, Kalapatapu R, et al. Remote electrical neuromodulation (REN) for acute treatment of migraine: A randomized, double-blind, placebo-controlled trial. Lancet Neurol. 2018;17(11):944-953.

[32] Schoenen J, Coppola G, Sun-Edelstein C, et al. Cefaly, a new device for the treatment of migraine: A randomized controlled trial. Cephalalgia. 2013;33(10):777-783.

[33] Schurks M, Rist PM, Bigal ME, et al. Caffeine as a trigger of migraines: A systematic review. Cephalalgia. 2009;29(4):410-418.

[34] Buse DC, Manack A, Fanning KM, et al. Assessment of the impact of alcohol use on migraine frequency and severity. Headache. 2012;52(10):1600-1609.

[35] Whelan AM, Stoltzfus J, Trowbridge M. The impact of diet and nutrition on migraine management. Curr Pain Headache Rep. 2015;19(6):32.

[36] Higgins P, Caddy C, Willson S. The role of tyramine-containing foods in the management of migraine: A review of the literature. J Clin Neurosci. 2013;20(3):417-423.

[37] Sarchielli P, Alberti A, Coppola F, et al. Omega-3 fatty acids and migraine: A randomized, controlled study. Neurology. 2010;74(6):421-427.

[38] MacFarlane GJ, Smith M, Matthews G, et al. Dietary omega-3 fatty acids and the prevention of migraine. J Nutr. 2012;142(6):1050-1056.

[39] Schoonman GG, Fronczek R, Van Oosterhout WP, et al. The role of magnesium in the prevention of migraine. J Headache Pain. 2009;10(1):27-34.

[40] Buse DC, Greisman JD, Baigi K, et al. The role of riboflavin in the prevention and treatment of migraines: A systematic review. Headache. 2012;52(7):1063-1072.

[41] Sun-Edelstein C, Mauskop A. Magnesium in the management of migraines. Curr Pain Headache Rep. 2009;13(5):305-310.

[42] Barbanti P, Fofi L, Aurilia C, et al. Coenzyme Q10 in migraine prevention: A randomized controlled trial. Neurology. 2010;74(20):1587-1594.

[43] Murtagh D, Smolensky M. Melatonin and its effects on migraine. Sleep Med Clin. 2008;3(2):231-240.

[44] Holroyd KA, Penzien DB, Rains JC, et al. Cognitive-behavioral therapy for migraine. Headache. 2004;44(3):285-298.

[45] Cahn BR, Polak P, Dingle A, et al. The role of mindfulness meditation in migraine treatment. J Pain Res. 2016;9:573-577.

[46] Nestoriuc Y, Martin A, Rief W. Biofeedback for the treatment of chronic pain: A meta-analysis. J Consult Clin Psychol. 2008;76(3):379-394.

[47] Lee JH, Choi TY, Lee MS, et al. Acupuncture for acute low back pain: A systematic review. Clin J Pain. 2013;29(3):172-183.

[48] Tough EA, White AR, Richards SH, et al. The role of massage therapy in reducing migraine symptoms. Headache. 2009;49(9):1363-1371.

[49] Lee JH, Choi TY, Lee MS, et al. Chiropractic spinal manipulation for migraine: A systematic review. J Clin Neurol. 2013;9(3):128-133.

[50] Kim Y, Park S, Kim H. Sleep hygiene and migraine prevention. J Headache Pain. 2016;17(1):45.

Similar Articles

51-60 of 103

You may also start an advanced similarity search for this article.